Mukka Proteins Approves Preferential Issue of Warrants Worth ₹47 Cr

Mukka Proteins Ltd's Board of Directors has approved a preferential issue of up to 2 crore Fully Convertible Warrants to identified non-promoter entities at an issue price of ₹23.50 per warrant. This issue aims to raise approximately ₹47 crore. Each warrant is convertible into one equity share within 18 months, subject to shareholder and regulatory approvals. The company also approved the draft postal ballot notice and fixed the e-voting period. Additionally, Mukka Proteins will invest up to ₹11.10 crore in Delta Marine Products and ₹15 crore in Aqua Marine, both partnership firms.